BCRX vs TYL · rev $374.7M vs P/E 89, rev $1.26B
BioCryst Pharmaceuticals Inc (BCRX) versus Tyler Technologies Inc (TYL) — a side-by-side from cached financials, not a winner call.
BioCryst Pharmaceuticals Inc (BCRX) is a drug manufacturers - specialty & generic company listed on US.
Tyler Technologies Inc (TYL) is a software - application company listed on US.
Latest reported BCRX revenue for 2026-06-30 was $374.7M. Net income was -$643.4M. BCRX currently screens at market cap $1.83B.
Latest reported TYL revenue for 2026-06-30 was $1.26B. Net income was $174.7M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
BCRX currently screens at market cap $1.83B. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
Not investment advice. Open the BCRX and TYL stock pages for the full models.
Not investment advice.